Arcturus Therapeutics In... (ARCT)
10.21
0.78 (8.27%)
At close: Apr 02, 2025, 3:59 PM
9.99
-2.07%
After-hours: Apr 02, 2025, 07:55 PM EDT
Arcturus Therapeutics Income Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
| Revenue | 152.31M | 157.75M | 205.75M | 12.36M | 9.54M | 20.79M | 15.75M | 13M | 20.38M | 6.14M | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 2.96M | 143.05M | 171.86M | 55.95M | 32.44M | 16.98M | 410K | 294K | 51K | n/a | n/a | n/a | n/a |
| Gross Profit | 152.31M | 154.79M | 62.7M | -159.5M | -46.41M | -11.65M | -1.23M | 12.59M | 20.09M | 6.09M | n/a | n/a | n/a | n/a |
| Operating Income | -95.67M | -78.2M | 12.18M | -202.85M | -71.52M | -25.51M | -21.81M | -10.49M | -25.17M | -19.7M | -33.08M | -10.29M | -1.5M | -3.91M |
| Interest Income | 15.2M | 17.36M | 2.58M | 753K | 470K | 408K | 514K | 89K | 798K | 338K | 239K | 22K | 2K | 21K |
| Pretax Income | -80.94M | -27.89M | 10.64M | -203.67M | -72.15M | -25.99M | -21.79M | -10.9M | -24.53M | -19.4M | -32.85M | -10.49M | -1.58M | -3.93M |
| Net Income | -80.94M | -29.73M | 9.35M | -206.86M | -71.36M | -25.72M | -21.79M | -10.9M | -24.6M | -19.45M | -32.83M | -10.55M | -1.58M | -3.93M |
| Selling & General & Admin | 52.82M | 52.87M | 46.07M | 41.45M | 23.22M | 12.66M | 20.58M | 7.57M | 5.36M | 4.99M | 5.84M | 3.22M | 683K | 2.08M |
| Research & Development | 195.16M | 192.13M | 147.75M | 173.76M | 57.85M | 33.64M | 16.98M | 15.92M | 18.39M | 13.46M | 25.11M | 7.07M | 818K | 1.82M |
| Other Expenses | n/a | -9.05M | -244K | n/a | n/a | n/a | n/a | -348K | 1.42M | 1.25M | 2.13M | n/a | n/a | n/a |
| Operating Expenses | 247.98M | 235.95M | 193.58M | 215.21M | 81.06M | 46.3M | 37.56M | 23.49M | 25.17M | 19.7M | 33.08M | 10.29M | 1.5M | 3.91M |
| Interest Expense | n/a | 767K | 420K | 2.67M | 361K | 446K | 186K | 150K | 295K | 251K | 2K | 197K | 80K | 44K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 247.98M | 245M | 193.58M | 215.21M | 81.06M | 46.3M | 37.56M | 23.49M | 25.17M | 19.7M | 33.08M | 10.29M | 1.5M | 3.91M |
| Income Tax | -4K | 1.83M | 1.29M | 3.19M | -784K | -270K | 212K | 1K | 73K | 51K | -17K | 61K | 65K | 21K |
| Shares Outstanding (Basic) | 27M | 26.63M | 26.45M | 26.32M | 20.3M | 12.07M | 10.07M | 3.09M | 3.94M | 3.09M | 1.95M | 1.45M | 1.59M | 1.59M |
| Shares Outstanding (Diluted) | 27M | 26.63M | 27.09M | 26.32M | 20.3M | 12.07M | 10.07M | 3.09M | 3.94M | 3.09M | 1.95M | 1.45M | 1.59M | 1.59M |
| EPS (Basic) | -3 | -1.12 | 0.35 | -7.86 | -3.51 | -2.13 | -2.16 | -3.53 | -6.25 | -6.29 | -16.81 | -7.25 | -0.99 | -2.47 |
| EPS (Diluted) | -3 | -1.12 | 0.35 | -7.86 | -3.51 | -2.13 | -2.16 | -3.53 | -6.25 | -6.29 | -16.81 | -7.25 | -0.99 | -2.47 |
| EBITDA | -77.4M | -24.17M | 13.7M | -201.66M | -70.64M | -24.42M | -20.71M | -10.34M | -947K | -1.72M | -32.81M | -10.28M | -1.51M | -3.92M |
| EBIT | -80.94M | -27.12M | 13.64M | -202.85M | -71.32M | -25.11M | -21.3M | -10.75M | -1.24M | -1.65M | -32.84M | -10.28M | -1.51M | -3.93M |
| Depreciation & Amortization | 3.54M | 2.96M | 1.53M | 1.19M | 882K | 684K | 582K | 410K | 294K | 51K | 31K | 8K | 7K | 6K |